An in-depth look to SCHOTT PHARMA AG & CO. KGAA operating, investing, and financing activities

1SXP free cash flow for Q3 24 is 34.05 M EUR. For 2023, 1SXP free cash flow was 6.18 M EUR and operating cash flow was 181.65 M EUR.